Rytelo Injection, Powder, Lyophilized, For Solution
Product Images NDC 82959-112
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rytelo (NDC 82959-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Geron Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (47 mg Vial Label)
The text provides information about a pharmaceutical product stored at temperatures between 2°C to 8°C (36°F to 46°F), emphasizing not to freeze it. The product is in the form of a vial containing 47mg and is intended for intravenous infusion after reconstitution and dilution. The manufacturer is Patheon Italia, S.p.A. The label includes codes like 16278 GER001-01, L02LL 65628 SN, and NDC 82959-112-01. It is mentioned that any unused portion should be discarded and is for prescription use only. The name of the product is RYTELO with prescription dosage information. Storage instructions require refrigeration.*
Principal Display Panel (47 mg Vial Carton)
This text provides information on a medication called RYTELO for injection, manufactured by Geron Corporation. The product contains 47 mg of imetelstat and is meant for intravenous infusion. The storage instructions include refrigeration at 2°C to 8°C and avoiding freezing. It also lists the inactive ingredients and advises on dosage per prescribing information. The manufacturer's address is in Foster City, CA, and the product is made by Patheon Italia S.p.A in Italy.*
Principal Display Panel (188 mg Vial Label)
This text provides information about the storage and usage of a medication called RYTELO, with dosage guidance for prescribing. The medication is stored in a refrigerator at a temperature range of 2°C to 8°C and is intended for intravenous infusion after reconstitution and dilution. The medication is produced by Catalent Indiana, LLC and is a product of South Korea. The packaging is a single-dose vial, and any unused portion should be discarded.*
Principal Display Panel (188 mg Vial Carton)
This text appears to be related to a medication called RYTELO (imetelstat) for Injection. It provides information about the contents, dosages available (88 mg/vial and 188 mg/vial), manufacturing details, and instructions for intravenous infusion. It also mentions the need for reconstitution and dilution before administration and includes guidance for healthcare providers to dispense the medication to patients. Additionally, it suggests discarding any unused portion of the single-dose vial.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.